Skip to main content

Neuromyelitis Optica Spectrum Disorder Medications

Find prices and information on Neuromyelitis Optica Spectrum Disorder medications.

Key takeaways

Medications for neuromyelitis optica spectrum disorder (NMOSD) are used to treat this condition and reduce the risk of relapses. They work by targeting the immune system to reduce inflammation and prevent attacks on the nervous system. Common classes include monoclonal antibodies complement inhibitors. Monoclonal antibodies like Enspryng (satralizumab) and Uplizna (inebilizumab)are usually given as injections. Complement inhibitors, such as Ultomiris (ravulizumab), are also injections. These treatments offer different ways to help manage NMOSD and improve your quality of life.

Prices for popular Neuromyelitis Optica Spectrum Disorder medications
Viewing 6 of 6 medications
SATRALIZUMAB treats neuromyelitis optica spectrum disorder (NMOSD), a condition that causes inflammation in the nerves of the eyes and spinal cord. It works by decreasing inflammation. It is a monoclonal antibody.
Bkemv is part of the Complement Inhibitors class and treats Myasthenia Gravis, Neuromyelitis Optica Spectrum Disorder and Paroxysmal Nocturnal Hemoglobinuria. Complement inhibitors are a type of monoclonal antibody that are used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). They prevent a part of the immune system from harming healthy cells and tissue. Bkemv is only available as a brand name drug.
Epysqli is part of the Complement Inhibitors class and treats Myasthenia Gravis, Neuromyelitis Optica Spectrum Disorder and Paroxysmal Nocturnal Hemoglobinuria. Complement inhibitors are a type of monoclonal antibody that are used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). They prevent a part of the immune system from harming healthy cells and tissue. Epysqli is only available as a brand name drug.
ECULIZUMAB treats certain blood conditions that can cause low levels of red blood cells (anemia) and blood clots, such as atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). It works by slowing down an overactive immune system, which reduces the breakdown of red blood cells. It also prevents blood cells (platelets) from forming a clot. It may also be used to treat a condition that causes muscles to easily weaken or fatigue (myasthenia gravis).
ECULIZUMAB treats certain blood conditions that can cause low levels of red blood cells (anemia) and blood clots, such as atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). It works by slowing down an overactive immune system, which reduces the breakdown of red blood cells. It also prevents blood cells (platelets) from forming a clot. It may also be used to treat a condition that causes muscles to easily weaken or fatigue (myasthenia gravis).
View otherCD19 Antibodies
INEBILIZUMAB treats neuromyelitis optica spectrum disorder (NMOSD), a condition that causes inflammation in the nerves of the eyes and spinal cord. It is a monoclonal antibody.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

Subscribe and save

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up

By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men's health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.

Browse medications

View All
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.